Latest updates

12 July

2017

Bulletins

Supreme Court concludes Actavis’ pemetrexed products directly infringe Eli Lilly’s patent

The UK Supreme Court (SC) has today handed down its judgment in the on-going dispute between Eli Lilly and Actavis relating to anti-cancer drugs including pemetrexed. It was announced last week that the SC had found in favour of Eli Lilly, by concluding that Actavis’ products directly and indirectly infringe Lilly’s patent in the UK,

11 July

2017

Bulletins

Nestlé’s struggle to catch a break

On 17 May 2017, the Court of Appeal handed down its judgment in Nestlé’s appeal against Arnold J’s decision in the High Court that the shape of Nestlé’s four fingered Kit Kat bar is not registrable as a trade mark. The Court of Appeal’s decision turned on whether Nestlé’s use of the shape mark had

7 July

2017

News

Breaking news- UK Supreme Court decides that Actavis UK Limited’s Pemetrexed products directly infringe Eli Lilly & Company’s European Patent EP1313508

Today, the UK Supreme Court (UKSC) has released a summary of its decision concerning alleged infringement of Eli Lilly & Company’s European patent EP1313508 (“the Patent”) by Actavis UK Limited and others. The UKSC has decided that Actavis UK Limited’s pemetrexed diacid, dipotassium or ditromethamine products do directly infringe the Patent in the UK as

30 June

2017

Bulletins

EPO excludes from patentability “plants and animals exclusively obtained by an essentially biological breeding process”

The EPO has announced that its Administrative Council has taken the decision to amend the relevant Regulations in order to exclude from patentability “plants and animals exclusively obtained by an essentially biological breeding process”. The new provisions will apply from 1 July 2017. By way of background, in November 2016 the European Commission issued a

28 June

2017

News

UK continues to move forward with UPC ratification

Despite the recent delays to the Unified Patent Court (UPC) timetable reported here, secondary legislation necessary for the UPC has this week been laid before Parliament in the UK.  The secondary legislation in question is an Order which would give effect in the UK to the UPC Protocol on Privileges and Immunities.  Similar secondary legislation

1 2 3 47

Events

September 2017

Attendees: Rohan Setna, Michelle Pratt, Simon Kahn

CIPA Congress 2017, London, September 2017

September 2017

Attendees: Charlotte Duly, Daniela Paull

Marques 31st Annual Conference, Prague, Czech Republic, September 2017

August 2017

Attendee: Matthew Spencer

IP Law Summer School, Speaker, Cambridge, August 2017

July 2017

Attendee: Jennifer O’Farrell

The Knowledge Group, Webinar speaker, Patent Protection for Pharma and Biotechnology in 2017, July 2017

July 2017

Attendee: Matthew Cornwell

One Nucleus, ON Helix 2017, Cambridge, July 2017

July 2017

Attendee: Jennifer O’Farrell

Gowling WLG Life Sciences Seminar, London, July 2017

June 2017

Attendee: Catherine Wolfe

ECTA 36th Annual Conference, Speaker, Budapest, Hungary, June 2017

Hover to read more

Catherine Wolfe has been invited to speak at the ECTA 36th Annual conference on the legal consequences of Brexit.

June 2017

Attendee: James Legg

BIO International Convention, San Diego, US, June 2017

June 2017

Attendee: Matthew Spencer

BIO International Convention, Speaker, San Diego, US, June 2017

Hover to read more

Matthew will be moderating a panel session exploring the impact of Brexit on the future for patent prosecution, litigation and commercial transactions involving patents in Europe.

June 2017

Attendees: Joanna Peak, Nadia Tyler-Rubinstein

BIA Women in Biotech Networking Evening, London, June 2017

June 2017

Attendee: Tony Pluckrose

ACiD’s Young Furniture Makers’ Industry Experience IP Master Class, Speaker, London, June 2017

INTA Annual Conference, Barcelona, Spain, May 2017

May 2017

Attendee: Nigel Tucker

All Energy exhibition and conference, Glasgow, May 2017

May 2017

Attendee: Jennifer O’Farrell

BioTrinity 2017, London, May 2017

boult.bites

boult.bites TM – Summer 2017

In this edition of Boult. bites, we look back INTA 2017; we look at what constitutes ‘similar and/or complementary good and services’; we advise on maintaining trade mark rights in the EU, and finally highlight an often overlooked ground of revocation that trade mark owners should be aware of.

boult.bites Biotech – Spring 2017

The ten minute read that highlights topical issues for bio and life science sector participants.

boult.bites TM – Spring 2017

In this edition of Boult. bites, we look at the need to be prudent when dealing with trade mark law in China; we analyse if your name can be separated from your person; we highlight the use of trade marked keys words in SEO campaigns, and finally offer a useful reminder of the difficulties claimants face when establishing a successful passing off claim, in relation to get-up.

Industry news

Guest posts from other sources. Clicking on the links will take you to an external site.

Search